Young People with Advanced Colorectal Cancer Do As Well with Chemotherapy as Older Patients

When colorectal cancer spreads to other parts of the body, young people under 50 who get chemotherapy benefit as much as those who are older. With drug combinations, there is no difference between those under 50 and those who are 50 and older in responding to chemotherapy, how long it takes before cancer gets worse, or…  Read More

ASCO Advises Oncologists: Test for KRAS Mutations

The American Society for Clinical Oncology (ASCO) has published a provisional clinical opinion (PCO) advising doctors to test patients with colorectal cancer for KRAS mutations before treating them with medicines that include Erbitux® (cetuximab) or Vectibix™ (panitumumab). The consensus of experts who reviewed recent research was that patients with metastatic colorectal cancer whose tumors have mutations in…  Read More

ASCO Issues Opinion on KRAS Testing

An panel of experts at the American Society of Clinical Oncology recommends that all patients who are being considered for anti-EGFR therapy have their tumors tested for the KRAS gene. If mutations are found, the panel says they should not be treated with Erbitux® (cetuximab) or Vectibix™ (panitumumab).

Age and Gender Affect Survival in Metastatic Colorectal Cancer

More News from ASCO 2008 Although men and women with metastatic colon or rectal cancer have similar overall survival after their diagnosis, age has an impact.  Women in premenopausal years, 18 to 44, live longer than younger men.  However, after the age of 75, women have significant worse survival than men. Across all age groups, Hispanics…  Read More

Provigil Helps Cancer Fatigue

Update from 2008 ASCO Meeting in Chicago Provigil® (modafinil) reduced fatigue in cancer patients receiving chemotherapy according to a study reported by Gary Morrow PhD at the 2008 ASCO meeting. Patients who were severely fatigued after their first chemotherapy treatment had less fatigue after they received Provigil than those who got a placebo. They were also…  Read More

Patricia Ganz M.D. Receives American Cancer Society Award at ASCO

Update from 2008 ASCO Meeting in Chicago Patricia Ganz, MD received the American Cancer Society Award at ASCO this year.  Professor of Medicine at the University of California at Los Angeles and Director of Cancer Prevention and Research at Jonsson Comprehensive Cancer Center, Dr. Ganz has a long history of concern for cancer patients and their…  Read More